Pyrazoloquinazoline Tricyclic System as Novel Scaffold to Design New Kinase CK2 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|4|281-284

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.4, 2006-05, pp. : 281-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein kinase CK2 inhibitors: a patent review

By Cozza Giorgio   Pinna Lorenzo A   Moro Stefano  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1081-1097

Informa Healthcare

Access to resources Recommend Favorite

ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-06 ,pp. : 1340-1351

Bentham Science Publishers

Access to resources Recommend Favorite

Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors

By Park C.H.   Siomboing X.   Yous S.   Gressier B.   Luyckx M.   Chavatte P.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 6, 2002-06 ,pp. : 461-468

Elsevier

Access to resources Recommend Favorite

Kinase CK2 Inhibition: An Update

By  

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 671-693

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Selective Inhibitors of Tyrosine Kinase 2

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-11 ,pp. : 507-515

Bentham Science Publishers

Access to resources Recommend Favorite